Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Comment by Mbxwatcheron Feb 04, 2022 1:48pm
103 Views
Post# 34398657

RE:RE:Price and Volume are Worth Watching

RE:RE:Price and Volume are Worth WatchingBased on this, you (perhaps correctly), are implying that Microbix is still seen as a Covid play.
Sad because that conversation has been  had multiple times over the last year, and the Company continues to insist that it is much more than a Covid play and will benefit from a return to normality because testing for things other than Covid will return to normal.  In fact they are certain there is a hangover from the lack of testing for other things over the past two years.

Regardless of what they say however, you imply that the market sees it as a pure Covid play.
If in fact your are right, (and I suspect to a degree that you are), the only proof is to see positive results in a post pandemic world I guess.

That, or another wave of new and unknown variant, which frankly I dont think anybody wants or needs.

It is hard to watch the stock price so far in 2022 so far, I will admit to that.
<< Previous
Bullboard Posts
Next >>